Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
59
SYRE Quote, Financials, Valuation and Earnings
Last price:
$33.11
Seasonality move
:
14.35%
Day range:
$32.79 - $34.10
52-week range:
$10.91 - $35.31
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
701.12x
P/B ratio:
5.63x
Volume:
292K
Avg. volume:
814.3K
1-year change:
41.6%
Market cap:
$2.6B
Revenue:
--
EPS (TTM):
-$2.18
SYRE Analysts' Consensus Rating
The 16 analysts providing 12-month price projections for Spyre Therapeutics, Inc. shares anticipate an average target of $54.29, ranging from a low estimate of $21.00 to a high estimate of $70.00. This average target implies a growth of 64.25% compared to the current stock price of $33.05.
Consensus Price Target
$54.29
Highest Price Target
$70.00
Lowest Price Target
$21.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 12 | 13 | 16 |
| Hold | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
SYRE Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 0.7% over the past day.
Buy
68
KOD alert for Dec 26
Kodiak Sciences, Inc. [KOD] is down 1.61% over the past day.
Buy
64
ZCSH alert for Dec 23
Grayscale Zcash Trust (ZEC) [ZCSH] is down 0% over the past day.
